Literature DB >> 24258451

Production of fat-1 transgenic rats using a post-natal female germline stem cell line.

Li Zhou1, Lei Wang, Jing X Kang, Wenhai Xie, Xiaoyong Li, Changqing Wu, Bo Xu, Ji Wu.   

Abstract

Germline stem cell lines possess the abilities of self-renewal and differentiation, and have been established from both mouse and human ovaries. Here, we established a new female germline stem cell (FGSC) line from post-natal rats by immunomagnetic sorting for Fragilis, which showed a normal karyotype, high telomerase activity, and a consistent gene expression pattern of primordial germ cells after 1 year of culture. Using an in vitro differentiation system, the FGSC line could differentiate into oocytes. After liposome-based transfection with green fluorescent protein (GFP) or fat-1 vectors, the FGSCs were transplanted into the ovaries of infertile rats. The transplanted FGSCs underwent oogenesis, and the rats produced offspring carrying the GFP or fat-1 transgene after mating with wild-type male rats. The efficiency of gene transfer was 27.86-28.00%, and 2 months was needed to produce transgenic rats. These findings have implications in biomedical research and potential applications in biotechnology.

Entities:  

Keywords:  animal model; cell culture; cell proliferation; germ cells

Mesh:

Substances:

Year:  2013        PMID: 24258451     DOI: 10.1093/molehr/gat081

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  51 in total

1.  Germ stem cells are active in postnatal mouse ovary under physiological conditions.

Authors:  Kun Guo; Chao-Hui Li; Xin-Yi Wang; Da-Jian He; Ping Zheng
Journal:  Mol Hum Reprod       Date:  2016-02-24       Impact factor: 4.025

2.  Use of DEAD-box polypeptide-4 (Ddx4) gene promoter-driven fluorescent reporter mice to identify mitotically active germ cells in post-natal mouse ovaries.

Authors:  Eun-Sil Park; Jonathan L Tilly
Journal:  Mol Hum Reprod       Date:  2014-08-21       Impact factor: 4.025

Review 3.  Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function.

Authors:  Alisha M Truman; Jonathan L Tilly; Dori C Woods
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

4.  Isolation and characterization of string-forming female germline stem cells from ovaries of neonatal mice.

Authors:  Jing Liu; Dantong Shang; Yao Xiao; Pei Zhong; Hanhua Cheng; Rongjia Zhou
Journal:  J Biol Chem       Date:  2017-08-21       Impact factor: 5.157

5.  Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.

Authors:  Changqing Wu; Bo Xu; Xiaoyong Li; Wenzhi Ma; Ping Zhang; Xuejin Chen; Ji Wu
Journal:  Mol Ther       Date:  2017-05-18       Impact factor: 11.454

6.  Cadherin 22 participates in the self-renewal of mouse female germ line stem cells via interaction with JAK2 and β-catenin.

Authors:  Xiaoyu Zhang; Yang Yang; Qin Xia; Hongfei Song; Rui Wei; Jingjing Wang; Kang Zou
Journal:  Cell Mol Life Sci       Date:  2017-10-24       Impact factor: 9.261

7.  Extracellular matrix signaling activates differentiation of adult ovary-derived oogonial stem cells in a species-specific manner.

Authors:  Julie A MacDonald; Yasushi Takai; Osamu Ishihara; Hiroyuki Seki; Dori C Woods; Jonathan L Tilly
Journal:  Fertil Steril       Date:  2019-03-11       Impact factor: 7.329

Review 8.  Autologous Germline Mitochondrial Energy Transfer (AUGMENT) in Human Assisted Reproduction.

Authors:  Dori C Woods; Jonathan L Tilly
Journal:  Semin Reprod Med       Date:  2015-11-17       Impact factor: 1.303

9.  Characterization of female germline stem cells from adult mouse ovaries and the role of rapamycin on them.

Authors:  Hong Yang; Xi Yao; Furong Tang; Yudong Wei; Jinlian Hua; Sha Peng
Journal:  Cytotechnology       Date:  2018-01-25       Impact factor: 2.058

10.  Woods and Tilly reply.

Authors:  Dori C Woods; Jonathan L Tilly
Journal:  Nat Med       Date:  2015-10       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.